UBS AM’s MediWound MDWD Stock Holding History

UBS AM’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49K	Hold	101	–	–	﹤0.01%	3581
2026 Q1	$1.63K	Buy	+101	New	+$1.76K	﹤0.01%	3633

Other funds holding MDWD

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM's MDWD Position: Q2 2026 in Review

UBS AM held its MediWound (MDWD) position steady in Q2 2026 at 101 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #3581.

UBS AM first reported a position in MDWD in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.63K in Q1 2026. 79 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

UBS AM held 101 shares of MediWound worth $1.49K as of Q2 2026.
UBS AM left its MediWound share count unchanged in Q2 2026.
MediWound made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3581 holding.
UBS AM first reported a position in MediWound in Q1 2026 and has held it in 2 quarters since.
UBS AM's MediWound position peaked at $1.63K in Q1 2026.
79 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.